Related Experiment Videos
Simple graphic method for estimation of prostate-specific antigen doubling time.
Shomik Sengupta1, Jeffrey M Slezak, Michael L Blute
1Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Urology
|February 8, 2006
Summary
Prostate-specific antigen doubling time (PSADT) estimation for prostate cancer prognosis is simplified. A new graphic tool estimates PSADT using two PSA measurements taken 3-12 months apart, avoiding complex algorithms.
Area of Science:
- Oncology
- Biostatistics
Background:
- Prostate-specific antigen doubling time (PSADT) is a crucial prognostic marker in prostate cancer management.
- Current PSADT estimation often relies on complex computerized algorithms, limiting accessibility.
Purpose of the Study:
- To introduce a straightforward graphic tool for estimating PSADT.
- To provide an alternative to computational methods for PSADT calculation.
Main Methods:
- The study presents a novel graphic tool for PSADT estimation.
- The tool utilizes two sequential prostate-specific antigen (PSA) measurements.
- Measurements must be separated by an interval of 3 to 12 months.
Main Results:
- The graphic tool offers a simplified method for PSADT estimation.
- This approach facilitates easier prognostic assessment for prostate cancer patients.
Conclusions:
- A simple graphic tool can effectively estimate PSADT, aiding in prostate cancer prognosis.
- This method enhances accessibility for clinicians and researchers in evaluating disease progression.